Phlegmon medical therapy

Revision as of 18:42, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Phlegmon Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Phlegmon from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phlegmon medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phlegmon medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onPhlegmon medical therapy

CDC on Phlegmon medical therapy

Phlegmon medical therapy in the news

Blogs on Phlegmon medical therapy

Directions to Hospitals Treating Phlegmon

Risk calculators and risk factors for Phlegmon medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The main goal of treatment is to remove the cause of phlegmonous process in order to achieve effective treatment and prevention of recurrence. If a patient's condition is mild, and the signs of the inflammatory process is present without signs of infiltrates, then conservative treatment with antibiotics is sufficient.

References



Linked-in.jpg